• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Eunethydis:关于 ADHD 指南欧洲小组及其成员与商业盈利组织之间关系的伦理原则声明。

Eunethydis: a statement of the ethical principles governing the relationship between the European group for ADHD guidelines, and its members, with commercial for-profit organisations.

机构信息

Clinical Neuropsychology, Vrije Universiteit, Amsterdam, The Netherlands.

出版信息

Eur Child Adolesc Psychiatry. 2010 Sep;19(9):737-9. doi: 10.1007/s00787-010-0114-8. Epub 2010 Jun 12.

DOI:10.1007/s00787-010-0114-8
PMID:20549526
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3128714/
Abstract

The Eunethydis ADHD Guidelines group set out here the ethical principles governing the relationship between the group and industry. The principles set out here are provided to ensure that this is both done and seen to be done. The impetus for these guidelines comes from within the Group and is linked to the recognition for the need for an open and transparent basis for Group-industry relations, especially in the light of the present concern that the pharmaceutical industry may be exerting a growing influence on the actions of researchers and clinicians in the ADHD field.

摘要

Eunethydis ADHD 指南制定小组在此阐述了指导本小组与行业关系的伦理原则。本原则旨在确保工作的开展和外界对工作的认可。制定本指南的动力源于小组内部,这与建立一个公开透明的小组-行业关系基础的需求相关,尤其是鉴于目前人们担心制药行业可能会对 ADHD 领域的研究人员和临床医生的行为产生越来越大的影响。

相似文献

1
Eunethydis: a statement of the ethical principles governing the relationship between the European group for ADHD guidelines, and its members, with commercial for-profit organisations.Eunethydis:关于 ADHD 指南欧洲小组及其成员与商业盈利组织之间关系的伦理原则声明。
Eur Child Adolesc Psychiatry. 2010 Sep;19(9):737-9. doi: 10.1007/s00787-010-0114-8. Epub 2010 Jun 12.
2
The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES).学术科学家与制药业之间透明、道德和成功关系的必要性:尊重伦理和卓越科学小组(GREES)的观点。
Osteoporos Int. 2010 May;21(5):713-22. doi: 10.1007/s00198-010-1190-9. Epub 2010 Mar 18.
3
A perspective on commercial relationships between ophthalmology and industry.眼科与行业之间商业关系的视角。
Arch Ophthalmol. 2009 Sep;127(9):1194-202. doi: 10.1001/archophthalmol.2009.180.
4
Conflict of interest in the physician interface with the biomedical industry.医生与生物医学行业互动中的利益冲突。
Emerg Med Clin North Am. 2006 Aug;24(3):671-85. doi: 10.1016/j.emc.2006.05.008.
5
[Conflicts of interest in clinical practice. Ethical analysis of some relationships with the pharmaceutical industry].
Rev Med Chil. 2006 Dec;134(12):1576-82. doi: 10.4067/s0034-98872006001200014. Epub 2007 Jan 24.
6
Ethical issues in the relationships with industry: an ongoing challenge. New Guidelines open for public comment.
J Paediatr Child Health. 2005 Nov;41(11):558-60. doi: 10.1111/j.1440-1754.2005.00719.x.
7
DSM-IV supervisor voices concerns about the diagnostic manual.《精神疾病诊断与统计手册第四版》的监管者对该诊断手册表示担忧。
Monash Bioeth Rev. 2013 Sep;31(2):16-7.
8
The ethics of the medical-pharmaceutical relationship.医疗-医药关系的伦理。
Clin Dermatol. 2012 Mar-Apr;30(2):188-91. doi: 10.1016/j.clindermatol.2011.06.006.
9
Proposed guidelines for housestaff interaction with pharmaceutical companies.住院医师与制药公司互动的拟议指南。
Ann R Coll Physicians Surg Can. 1993 Oct;26(5):291-3.
10
Commentary: Addressing corporate influence through ethical guidelines.
Int J Epidemiol. 2008 Feb;37(1):57-9; discussion 65-8. doi: 10.1093/ije/dym267.

本文引用的文献

1
Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline.多动障碍的长效药物。系统评价与欧洲治疗指南。
Eur Child Adolesc Psychiatry. 2006 Dec;15(8):476-95. doi: 10.1007/s00787-006-0549-0. Epub 2006 May 5.
2
European clinical guidelines for hyperkinetic disorder -- first upgrade.欧洲多动障碍临床指南——首次更新。
Eur Child Adolesc Psychiatry. 2004;13 Suppl 1:I7-30. doi: 10.1007/s00787-004-1002-x.
3
Clinical guidelines for hyperkinetic disorder. European Society for Child and Adolescent Psychiatry.多动障碍临床指南。欧洲儿童和青少年精神病学会。
Eur Child Adolesc Psychiatry. 1998 Dec;7(4):184-200. doi: 10.1007/s007870050067.